Cargando…

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy

The treatment of refractory Helicobacter pylori remains challenging in clinical practice. Factors that should be considered in the treatment of refractory H. pylori infection include treatment length, dosage of antibiotics and proton pump inhibitors (PPIs), number of drugs, and the selection of appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liou, Jyh-Ming, Lee, Yi-Chia, Wu, Ming-Shiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761919/ https://www.ncbi.nlm.nih.gov/pubmed/33782215 http://dx.doi.org/10.5009/gnl20330

Ejemplares similares

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

The interplay between Helicobacter pylori and gastrointestinal microbiota
por: Chen, Chieh-Chang, et al.
Publicado: (2021)

Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
por: Lee, Yi-Chia, et al.
Publicado: (2016)

Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention
por: Liou, Jyh-Ming, et al.
Publicado: (2019)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2016)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
por: Tsai, Kun-Feng, et al.
Publicado: (2017)

Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022)

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2017)

Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review
por: Gisbert, Javier P.
Publicado: (2020)

miR-21 Targets ASPP2 to Inhibit Apoptosis via CHOP-Mediated Signaling in Helicobacter pylori-Infected Gastric Cancer Cells
por: Huang, Bo-Shih, et al.
Publicado: (2023)

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012)

Consensus on the clinical management, screening‐to‐treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
por: Sheu, Bor‐Shyang, et al.
Publicado: (2017)

Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection
por: Ho, Cheng-Yu, et al.
Publicado: (2022)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
por: Kuo, Chia-Jung, et al.
Publicado: (2020)

Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations
por: Peng, Chao, et al.
Publicado: (2020)

Refractory Helicobacter pylori infection and the gastric microbiota
por: Liu, Dongsheng, et al.
Publicado: (2022)

Rescue therapy for refractory Helicobacter pylori infection: current status and future concepts
por: Wang, Song-Wei, et al.
Publicado: (2023)

Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
por: Chen, Chieh-Chang, et al.
Publicado: (2020)

Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review
por: de Moraes Andrade, Pedro Vieira, et al.
Publicado: (2023)

Helicobacter pylori infection is an infectious disease and the empiric therapy paradigm should be changed
por: Li, Hong, et al.
Publicado: (2019)

Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of Helicobacter pylori Infection
por: Perkovic, Nikola, et al.
Publicado: (2021)

Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection
por: Choe, A Reum, et al.
Publicado: (2021)

VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells
por: Yu, Cheng-Chou, et al.
Publicado: (2013)

Empirical versus tailored therapy based on genotypic resistance detection for Helicobacter pylori eradication: a systematic review and meta-analysis
por: Li, Meng, et al.
Publicado: (2023)

Determining the Association Between Helicobacter pylori Infection and Treatment-Refractory Hypothyroidism
por: Jamil, Muhammad Zahid Z, et al.
Publicado: (2022)

Treatment Approach of Refractory Helicobacter pylori Infection: A Comprehensive Review
por: Cortés, Pedro, et al.
Publicado: (2021)

Treatment of refractory Helicobacter pylori infection: A new challenge for clinicians
por: Xu, XinBo, et al.
Publicado: (2022)

Dual therapy for Helicobacter pylori infection
por: Duan, Miao, et al.
Publicado: (2023)

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention
por: Lee, Yi-Chia, et al.
Publicado: (2013)

Application of Visual Gene Clip-Based Tailored Therapy for the Eradication of Helicobacter pylori
por: Yang, Lili, et al.
Publicado: (2021)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Refractory Helicobacter pylori treatment in resource‐limited settings
por: Mahadeva, Sanjiv
Publicado: (2023)

Optimizing Helicobacter pylori Treatment: An Updated Review of Empirical and Susceptibility Test-Based Treatments
por: Ishibashi, Fumiaki, et al.
Publicado: (2023)

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum
por: Kuo, Yang-Che, et al.
Publicado: (2022)

Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection
por: Yang, Jyh-Chin, et al.
Publicado: (2013)

Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial
por: Choi, Youn I, et al.
Publicado: (2019)

Gastric MALT lymphoma refractory to Helicobacter pylori antibiotic therapy
por: Rohm, Charlene L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gj3loe01adu922817b4j3kl60n